VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 18 filers reported holding VASCULAR BIOGENICS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,029 | +6.3% | 20,575 | 0.0% | 0.00% | – |
| Q2 2023 | $4,733 | +37.3% | 20,575 | 0.0% | 0.00% | – |
| Q1 2023 | $3,447 | +68840.0% | 20,575 | -50.0% | 0.00% | – |
| Q4 2022 | $5 | -99.8% | 41,150 | +87.0% | 0.00% | – |
| Q3 2022 | $3,000 | -91.4% | 22,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $35,000 | -7.9% | 22,000 | -1.5% | 0.00% | +50.0% |
| Q1 2022 | $38,000 | -13.6% | 22,325 | +1.0% | 0.00% | 0.0% |
| Q4 2021 | $44,000 | -2.2% | 22,100 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $45,000 | -15.1% | 22,100 | +0.5% | 0.00% | -33.3% |
| Q2 2021 | $53,000 | +20.5% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $44,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
| Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
| DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
| PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
| Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
| Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
| HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
| MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
| Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |